ARCHIVES

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

This article is from The Cancer Letter archive.

Vol. 23 No. 06 | February 14, 1997

Download PDF Visit The Full Archive

Related Articles

Cancer Training Programs Fairing Fairley Well

December 1, 1989

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

In Brief: Top Priority: Keep Rauscher; Pay Raise Bill No Moving; Miller, Holland Head AACR, ASCO

May 21, 1976